A mathematical model of the impact of infused targeted cytotoxic agents on brain tumours: Implications for detection, design and delivery

Cell Proliferation

Volumn 35, Issue 6, 2002, Pages 343-361

  Wein, Lawrence M ^a   Wu, Joseph T ^b   Ianculescu, Alexandra G ^a   Puri, Raj K ^c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; HYBRID PROTEIN; INTERLEUKIN 4; PSEUDOMONAS EXOTOXIN;

ACCURACY; ARTICLE; CELL KILLING; CELL LOSS; CELL PROLIFERATION; DIFFUSION COEFFICIENT; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG INFUSION; DRUG PENETRATION; DRUG POTENCY; DRUG SPECIFICITY; GLIOBLASTOMA; HUMAN; MATHEMATICAL MODEL; PROBABILITY; TUMOR CELL; TUMOR DIAGNOSIS; TUMOR VOLUME;

PSEUDOMONAS;

EID: 0036434384     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2184.2002.00246.x     Document Type: Article

References (25)

1. Abramowitz M, Stegun IE (1972) Handbook of Mathematical Functions. Applied Mathematics Series 55. Washington, DC: National Bureau of Standards.
2. Adam JA, Bellomo N (1997) A Survey of Models for Tumor‐Immune System Dynamics. Boston, MA: Birkhäuser.
3. Basser PJ (1992) Interstitial pressure, volume, and flow during infusion into brain tissue. Microvascular Res. 44, 143.
4. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH (1994) Convection‐enhanced delivery of macromolecules in the brain. Proc. Natl Acad. Sci. USA 91, 2076.
5. Boucher Y, Salehi H, Witwer B, Harsh IVGR, Jain RK (1997) Interstitial fluid pressure in intracranial tumours in patients and in rodents. Br. J. Cancer 75, 829.
6. Burgess PK, Kulesa PM, Murray JD, Alvord EC J r (1997) The interaction of growth rates and diffusion coefficients in a three‐dimensional mathematical model of gliomas. J. Neuropath. Exp. Neurol. 56, 704.
7. Chen MY, Lonser RR, Morrison PF, Governale LS, Oldfield EH (1999) Variables affecting convection‐enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue‐cannula sealing time. J. Neurosurg. 90, 315.
8. De Jong MC, Scheffer GL, Slootsra JW, Broxterman HJ, Meloen RH, Husain SR, Joshi BH, Puri RK, Scheper RJ, (2000) Activity of a recombinant interleukin‐4‐pseudomonas exotoxin is reduced in tumor cell lines overexpressing the multidrug resistance protein MRP1, but not cell lines overexpressing P‐glycoprotein, breast cancer resistance protein, MRP2 or MRP3. 91st Annual Meeting Amer. Assoc. Cancer Res. April 1–5, 2000. Abstract #4294. Vol. 41, p. 675. San Francisco, CA: Amer. Assoc. Cancer Res.
9. Dillehay LE (1997) Decreasing resistance during fast infusion of a subcutaneous tumor. Anticancer Res. 17, 461.
10. Husain SR, Behari N, Kreitman RJ, Pastan I, Puri RK (1998) Complete regression of established human glioblastoma tumor xenograft by interleukin‐4 toxin therapy. Cancer Res. 58, 3649.
11. Husain SR, Kreitman RJ, Pastan I, Puri RK (1999) Interleukin‐4 receptor‐directed cytotoxin therapy of AIDS‐associated Kaposi's sarcoma tumors in xenograft model. Nature Med. 5, 817.
12. Laske DW, Morrison PF, Lieberman DM, Corthesy ME, Reynolds JC, Stewart‐Henney PA, Koong S, Cummins A, Paik CH, Oldfield EH (1997a) Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single‐photon emission computerized tomography imaging. J. Neurosurg 87, 586.
13. Laske DW, Youle RJ, Oldfield EH (1997b) Tumor regression with regional distribution of the targeted TF‐CRM107 in patients with malignant brain tumors. Nature Med. 3, 1362.
14. Lieberman DM, Laske DW, Morrison PF, Bankiewicz KS, Oldfield EH (1995) Convection‐enhanced distribution of large molecules in gray matter during interstitial drug infusion. J. Neurosurg 82, 1021.
15. Morrison PF, Dedrick RL (1986) Transport of cisplatin in rat brain following microinfusion. J. Pharm. Sci. 75, 120.
16. Morrison PF, Laske DW, Bobo H, Oldfield EH, Dedrick RL (1994) High‐flow microinfusion: tissue penetration and pharmacodynamics. Am. J. Physiol. 266, R292.
17. Puri RK, Hoon DS, Leland P, Snoy P, Rand RW, Pastan I, Kreitman RJ (1996) Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated pseudomonas exotoxin for therapy of malignant astrocytoma. Cancer Res. 56, 5631.
18. Puri RK, Leland P, Kreitman RJ, Pastan I (1994) Human neurological cancers express interleukin‐4 receptors which are targets for the toxic effects of IL‐4‐ Pseudomonas exotoxin chimeric protein. Int. J. Cancer 58, 574.
19. Rand RW, Kreitman RJ, Patronas N, Varricchio F, Pastan I, Puri RK (2000) Intratumoral administration of recombinant circularly permuted interleukin‐4‐ pseudomonas exotoxin in patients with high grade glioma. Clin. Cancer Res. (Adv. Brief) 6, 2157.
20. Saltzman WM, Radomsky ML (1991) Drugs released from polymers: diffusion and elimination in brain tissue. Chem. Engr. Sci. 46, 2429.
21. Swabb EA, Wei J, Gullino PM (1974) Diffusion and convection in normal and neoplastic tissues. Cancer Res. 34, 2814.
22. Swanson K (1999) Mathematical modeling of the growth and control of tumors. PhD Dissertation. Seattle, WA: Department of Applied Mathematics, University of Washington.
23. Tracqui P, Cruywagen GC, Woodward DE, Bartoo GT, Murray JD, Alvord EC J r (1995) A mathematical model of glioma growth: the effect of chemotherapy on spatio‐temporal growth. Cell Prolif. 28, 17.
24. Tucker SL, Taylor JMG (1996) Improved models of tumour cure. Int. J. Radiat. Biol. 70, 539.
25. Woodward DE, Cook J, Tracqui P, Cruywagen GC, Murray JD, Alvord EC J r (1996) A mathematical model of glioma growth: the effect of extent of surgical resection. Cell Prolif. 29, 269.